Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Medicines Agency
Pharma
EMA changes tune, endorses Leqembi with restriction
After a prior rejection, the EMA now recommends an approval to Leqembi, but only in mild Alzheimer's patients with one or no copy of the ApoE4 gene.
Angus Liu
Nov 14, 2024 12:10pm
Regulatory tracker: Sanofi aims to overturn NICE rejection
Nov 13, 2024 9:40am
J&J angles Darzalex for first move into early-stage myeloma
Nov 8, 2024 9:53am
Astellas pulls application for Izervay after talks with CHMP
Oct 28, 2024 11:07am
Shortages of Novo Nordisk's Ozempic to persist into Q4
Sep 3, 2024 11:14am
EU regulator calls for withdrawal of certain preterm birth drugs
May 17, 2024 10:37am
